Oftan Akvakol (Chloramphenicol)

Chloramphenicol, the active ingredient in Often Akvakol, is an antibiotic presented as a ophthalmic solution for topical eye use. It treats bacterial eye infections such as conjunctivitis and keratitis in patients requiring local antimicrobial therapy.

GNH USA supplies Often Akvakol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Chloramphenicol ophthalmic solution is used for bacterial infections of the ocular surface and related structures. - Conjunctivitis: reduces bacterial load and alleviates redness and discharge. - Keratitis: penetrates corneal tissue to control infection and prevent scarring. - Blepharitis: helps eliminate bacterial colonisation on eyelid margins. - Post‑surgical prophylaxis: lowers risk of infection after eye surgery. - Trachoma management: part of community‑based treatment programmes.

Adverse reactions to chloramphenicol eye drops are generally mild but can vary in severity.

Common Side Effects: - Stinging or burning sensation on instillation. - Temporary blurred vision. - Mild conjunctival hyperemia. - Local itching or irritation. - Mild eyelid edema.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Severe corneal ulceration. - Anaphylactic reaction. - Bone marrow suppression (systemic absorption).

When using chloramphenicol ophthalmic solution, follow safety guidelines to minimise risks. - Indication verification: ensure the infection is bacterial and suitable for topical therapy. - Duration of therapy: limit use to the prescribed period to avoid resistance. - Monitor for hypersensitivity: discontinue if signs of allergic reaction appear. - Systemic exposure: avoid excessive dosing that could lead to systemic absorption. - Store at below 25°C: keep in the original container, protect from light and moisture.

Chloramphenicol eye drops have limited systemic drug‑interaction potential, but certain combinations warrant caution.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use may increase risk of ototoxicity. - Systemic anticoagulants: may potentiate bleeding risk if significant systemic absorption occurs.

Moderate Interactions (Monitor Closely): - Other topical ophthalmic antibiotics: assess for additive toxicity. - Non‑steroidal anti‑inflammatory eye drops: monitor for delayed wound healing. - Systemic corticosteroids: may mask signs of infection.